Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2013	Jun. 24, 2012	Jun. 26, 2011
Cash and cash equivalents at beginning of year	$ 10,886	$ 27,490	$ 42,691
Operating activities:
Net income including non-controlling interest	15,670	10,828	25,089
Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:
Equity in earnings of unconsolidated affiliates	(11,444)	(19,740)	(24,352)
Dividends received from unconsolidated affiliates	14,940	10,616	5,900
Depreciation and amortization expense	24,584	27,135	25,977
Loss on extinguishment of debt	1,102	3,203	3,337
Loss on previously held equity interest		3,656
Non-cash compensation expense, net	2,287	2,382	1,394
Excess tax benefit on stock-based compensation plans	(762)		(2)
Deferred income taxes	6,010	(6,933)	327
Other	690	523	571
Changes in assets and liabilities, excluding effects of foreign currency adjustments:
Receivables, net	(858)	(4,496)	(5,877)
Inventories	(394)	13,140	(19,269)
Other current assets and income taxes receivable	(452)	(1,650)	977
Accounts payable and accrued expenses	(498)	3,698	(2,803)
Income taxes payable	(366)	947	611
Net cash provided by operating activities	50,509	43,309	11,880
Investing activities:
Capital expenditures	(8,809)	(6,354)	(20,539)
Investments in unconsolidated affiliates		(360)	(867)
Other investments	(1,743)
Proceeds from other investments	694
Acquisition, net of cash acquired		(356)
Return of capital from unconsolidated affiliate			500
Proceeds from sale of assets	430	507	269
Proceeds from return of split dollar life insurance premiums		14	3,241
Other	(343)	(309)
Net cash used in investing activities	(9,771)	(6,858)	(17,396)
Financing activities:
Payments on notes payable		(134,010)	(47,587)
Proceeds from revolving credit facilities	116,700	160,600	193,225
Payments on revolving credit facilities	(115,200)	(144,200)	(158,625)
Proceeds from issuance of term loans		80,000
Payments on term loans	(28,330)	(9,769)
Payments of debt financing fees	(309)	(3,127)	(825)
Proceeds from related party term loan	1,250
Repurchase and retirement of common stock	(19,315)		(1)
Proceeds from stock option exercises	1,298	71	146
Contributions from non-controlling interest	1,280	920
Excess tax benefit on stock-based compensation plans	762		2
Other	(69)	(319)	(364)
Net cash used in financing activities	(41,933)	(49,834)	(14,029)
Effect of exchange rate changes on cash and cash equivalents	(936)	(3,221)	4,344
Net decrease in cash and cash equivalents	(2,131)	(16,604)	(15,201)
Cash and cash equivalents at end of year	$ 8,755	$ 10,886	$ 27,490